TY - JOUR
T1 - Improving the discharge medication reconciliation process for an inpatient hematologic malignancies service by utilizing a pharmacist-facilitated workflow
AU - Seraphin, Megan
AU - Mirza, Zara
AU - Ahn, Esther
AU - Blake, Melonie
AU - Showel, Margaret
N1 - Funding Information:
The authors thank the hospitalist team at Sibley Memorial Hospital, Dr Khaled El-Shami, and Dr Leena Rahmat for their collaboration in implementing this initiative. The authors also acknowledge Dr Christopher Keeys for his guidance and mentorship throughout this study. Disclosure: The authors declare no relevant conflicts of interest or financial relationships. Funding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Publisher Copyright:
© 2022 American Pharmacists Association®
PY - 2023/1/1
Y1 - 2023/1/1
N2 - Background: There is an opportunity for pharmacists to play a greater role during discharge medication reconciliation (MR), particularly in the oncology setting. Objectives: This initiative aims to decrease the number of medication discrepancies that occur during discharge MR and improve physician satisfaction with the discharge MR process for patients discharged from an inpatient adult hematologic malignancies (HM) service. Practice description: Patients on the HM service at Sibley Memorial Hospital, a community hospital located in Washington, DC, are co-managed by hospitalists and HM oncologists. The care team for the service also includes nursing staff and a clinical pharmacist. Practice innovation: The HM service piloted a pharmacist-facilitated workflow that involved the clinical pharmacist reconciling inpatient and outpatient medications prior to discharge, reviewing the discharge MR with the HM oncologist, and pending the discharge MR in the electronic medical record for the discharging hospitalist to review and sign. Evaluation methods: Prior to pilot implementation, discharge MRs of patients discharged from the HM service from November 2021 to December 2021 were analyzed by a pharmacist to identify medication discrepancies through retrospective chart review. This process was repeated to analyze pharmacist-facilitated discharge MRs for discrepancies for patients discharged between December 2021 to April 2022. Physician satisfaction with the process was assessed via survey pre and post-pilot. Results: A total of 30 and 37 discharge MRs were analyzed pre- and post-pilot, respectively. There were 19 medications discrepancies identified in the pre-pilot group and 6 discrepancies noted in the post-pilot group (P=0.038). Median physician satisfaction with the process was found to be 3.3 pre-pilot, and 5 post-pilot (on a scale of 1-5, with 5 being very satisfied). Conclusion: A pharmacist-facilitated workflow for discharge MR increased the accuracy of the discharge MR for patients on the HM service and improved physician satisfaction with the discharge MR process.
AB - Background: There is an opportunity for pharmacists to play a greater role during discharge medication reconciliation (MR), particularly in the oncology setting. Objectives: This initiative aims to decrease the number of medication discrepancies that occur during discharge MR and improve physician satisfaction with the discharge MR process for patients discharged from an inpatient adult hematologic malignancies (HM) service. Practice description: Patients on the HM service at Sibley Memorial Hospital, a community hospital located in Washington, DC, are co-managed by hospitalists and HM oncologists. The care team for the service also includes nursing staff and a clinical pharmacist. Practice innovation: The HM service piloted a pharmacist-facilitated workflow that involved the clinical pharmacist reconciling inpatient and outpatient medications prior to discharge, reviewing the discharge MR with the HM oncologist, and pending the discharge MR in the electronic medical record for the discharging hospitalist to review and sign. Evaluation methods: Prior to pilot implementation, discharge MRs of patients discharged from the HM service from November 2021 to December 2021 were analyzed by a pharmacist to identify medication discrepancies through retrospective chart review. This process was repeated to analyze pharmacist-facilitated discharge MRs for discrepancies for patients discharged between December 2021 to April 2022. Physician satisfaction with the process was assessed via survey pre and post-pilot. Results: A total of 30 and 37 discharge MRs were analyzed pre- and post-pilot, respectively. There were 19 medications discrepancies identified in the pre-pilot group and 6 discrepancies noted in the post-pilot group (P=0.038). Median physician satisfaction with the process was found to be 3.3 pre-pilot, and 5 post-pilot (on a scale of 1-5, with 5 being very satisfied). Conclusion: A pharmacist-facilitated workflow for discharge MR increased the accuracy of the discharge MR for patients on the HM service and improved physician satisfaction with the discharge MR process.
UR - http://www.scopus.com/inward/record.url?scp=85141245160&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141245160&partnerID=8YFLogxK
U2 - 10.1016/j.japh.2022.09.023
DO - 10.1016/j.japh.2022.09.023
M3 - Article
AN - SCOPUS:85141245160
SN - 1544-3191
VL - 63
SP - 403
EP - 408
JO - Journal of the American Pharmacists Association
JF - Journal of the American Pharmacists Association
IS - 1
ER -